换一批
换一批Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease.
第一作者：
Dong,Wang
第一单位：
National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Suzhou, China.
作者：
主题词
青少年(Adolescent);成年人(Adult);慢性病(Chronic Disease);女(雌)性(Female);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);男(雄)性(Male);中年人(Middle Aged);腈类(Nitriles);吡唑类(Pyrazoles);嘧啶类(Pyrimidines);复发(Recurrence);回顾性研究(Retrospective Studies);挽救疗法(Salvage Therapy);青年人(Young Adult)
DOI
10.3389/fimmu.2021.673636
PMID
34276662
发布时间
2021-12-04
- 浏览0
Frontiers in immunology
673636页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
